Allakos Inc.
ANTI-SIGLEC-8 ANTIBODIES AND METHODS OF USE THEREOF

Last updated:

Abstract:

The invention provides humanized anti-Siglec-8 antibodies and their use in treating and preventing eosinophil-mediated disorders and/or mast cell-mediated disorders, as well as compositions and kits comprising the humanized anti-Siglec-8 antibodies.

Status:
Application
Type:

Utility

Filling date:

17 May 2019

Issue date:

20 Feb 2020